相关实验视频
Updated: Jun 21, 2025

09:15
In Vitro Thrombosis Test for Ventricular Assist Devices
Published on: March 21, 2025
551
怀孕期间抗血素检测和治疗:它们与临床结果的现实关系
Jerome J Federspiel1, Wilton Rodriguez2, Jeffrey Spears2
1Duke University, Durham, NC, United States.
Thrombosis research
|July 6, 2024
概括
在怀孕期间抗血素缺乏会增加风险. 这项研究分析了医疗保健数据,以确定改善低抗血素水平的孕妇护理和孕产妇结果的机会.
科学领域:
- 产科和妇科 产科和妇科
- 血液学 血液学 血液学
- 药物经济学 药物经济学
背景情况:
- 抗血素 (AT) 缺乏症是一种严重的血栓友爱症.
- 它与孕期和产后增加的孕产妇发病率,死亡率和医疗保健费用有关.
- 了解护理模式对于改善结果至关重要.
研究的目的:
- 为了评估医疗保健资源的利用和治疗模式,怀孕的个体与抗血素缺乏.
- 确定在高风险人群中优化护理和孕产妇结果的机会.
主要方法:
- 利用美国两大医疗保健数据库 (Cerner真实世界数据和Premier医疗保健数据库) 对15-44岁的女性进行了分娩相关的接触.
- 基于抗血素水平测试和抗血素度 (ATc) 处方创建的队列.
- 排除了接受心肺旁路术的个人.
主要成果:
- 分析了AT水平测试队列中的5411个人和ATc使用的较小队列.
- 发现5.4-7.9%的个体在与分娩相关的接触期间经历了血栓形成.
- 从分娩到产后一年的平均总成本是相当大的,其中很大一部分与异常凝血有关.
结论:
- 存在显著的机会,以提高低AT水平的孕妇的护理.
- 在整个怀孕期间优化管理是实现更好的孕产妇结果的关键.
- 进一步研究ATc的时间和有效性是有必要的.
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
672
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
672
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.2K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.2K
Rh Blood Group
1.4K
The Rhesus (Rh) antigen is crucial in determining blood groups and ensuring compatibility during blood transfusions.
1.4K
Teratogenicity
2.4K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.4K
Therapeutic Index
4.2K
The therapeutic index of a drug is a key parameter in pharmacology that quantifies the relative safety of a drug by calculating the ratio between the dose that causes toxicity in half the population (50%) to the dose that proves to be effective for half the population (50%). It provides a spectrum of doses for a particular drug ranging from effective to potentially toxic. To illustrate, consider an anticoagulant agent like warfarin. It possesses a narrow window within its therapeutic index to...
4.2K
Disorders of Hemostasis
824
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
824

